Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 172

1.

An immunohistochemical panel to differentiate metastatic breast carcinoma to skin from primary sweat gland carcinomas with a review of the literature.

Rollins-Raval M, Chivukula M, Tseng GC, Jukic D, Dabbs DJ.

Arch Pathol Lab Med. 2011 Aug;135(8):975-83. doi: 10.5858/2009-0445-OAR2. Review.

PMID:
21809988
2.

Epidermal growth factor, estrogen, and progesterone receptor expression in primary sweat gland carcinomas and primary and metastatic mammary carcinomas.

Busam KJ, Tan LK, Granter SR, Kohler S, Junkins-Hopkins J, Berwick M, Rosen PP.

Mod Pathol. 1999 Aug;12(8):786-93.

PMID:
10463481
4.

Immunohistochemical distinction of primary sweat gland carcinoma and metastatic breast carcinoma: can it always be accomplished reliably?

Mentrikoski MJ, Wick MR.

Am J Clin Pathol. 2015 Mar;143(3):430-6. doi: 10.1309/AJCP2N1AFXEFOVYE.

PMID:
25696802
5.

Usefulness of monoclonal antibody HIK1083 specific for gastric O-glycan in differentiating cutaneous metastasis of gastric cancer from primary sweat gland carcinoma.

Iijima M, Nakayama J, Nishizawa T, Ishida A, Ishii K, Ota H, Katsuyama T, Saida T.

Am J Dermatopathol. 2007 Oct;29(5):452-6.

PMID:
17890913
7.
8.

Utility of mammaglobin and gross cystic disease fluid protein-15 (GCDFP-15) in confirming a breast origin for recurrent tumors.

Chia SY, Thike AA, Cheok PY, Tan PH.

Breast. 2010 Oct;19(5):355-9. doi: 10.1016/j.breast.2010.02.007.

PMID:
20347310
9.

Comparative study of monoclonal antibody B72.3 and gross cystic disease fluid protein-15 as markers of apocrine carcinoma of the breast.

Honma N, Takubo K, Arai T, Younes M, Kasumi F, Akiyama F, Sakamoto G.

APMIS. 2006 Oct;114(10):712-9.

PMID:
17004974
12.

Immunohistochemical techniques to compare primary vs. metastatic mucinous carcinoma of the skin.

Levy G, Finkelstein A, McNiff JM.

J Cutan Pathol. 2010 Apr;37(4):411-5. doi: 10.1111/j.1600-0560.2009.01436.x.

PMID:
19788442
14.
15.

Immunoreactivity for estrogen receptor protein in sweat gland tumors.

Swanson PE, Mazoujian G, Mills SE, Campbell RJ, Wick MR.

Am J Surg Pathol. 1991 Sep;15(9):835-41.

PMID:
1951842
16.

A study of immunohistochemical differential expression in pulmonary and mammary carcinomas.

Yang M, Nonaka D.

Mod Pathol. 2010 May;23(5):654-61. doi: 10.1038/modpathol.2010.38.

17.

Her-2 expression in cutaneous eccrine and apocrine neoplasms.

Hiatt KM, Pillow JL, Smoller BR.

Mod Pathol. 2004 Jan;17(1):28-32.

18.

Podoplanin is a highly sensitive and specific marker to distinguish primary skin adnexal carcinomas from adenocarcinomas metastatic to skin.

Liang H, Wu H, Giorgadze TA, Sariya D, Bellucci KS, Veerappan R, Liegl B, Acs G, Elenitsas R, Shukla S, Youngberg GA, Coogan PS, Pasha T, Zhang PJ, Xu X.

Am J Surg Pathol. 2007 Feb;31(2):304-10.

PMID:
17255777
19.

Apocrine carcinomas of the breast in Turkish women: hormone receptors, c-erbB-2 and p53 immunoexpression.

Kaya H, Bozkurt SU, Erbarut I, Djamgoz MB.

Pathol Res Pract. 2008;204(6):367-71. doi: 10.1016/j.prp.2008.01.012.

PMID:
18342452
20.

Triple negative breast cancer: outcome correlation with immunohistochemical detection of basal markers.

Thike AA, Iqbal J, Cheok PY, Chong AP, Tse GM, Tan B, Tan P, Wong NS, Tan PH.

Am J Surg Pathol. 2010 Jul;34(7):956-64. doi: 10.1097/PAS.0b013e3181e02f45.

PMID:
20495445

Supplemental Content

Support Center